Notably, Tang et al. [40] developed a model, based on the combination of radiomic parameters from pre-treatment CT and tumor immune parameters (i.e., PD-L1 expression and density of TILs) from excised primary NSCLC, for predicting TME. The gene discussed is CD274; the disease is neoplasm.